Literature DB >> 9801712

Dual diagnosis: a review of etiological theories.

K T Mueser1, R E Drake, M A Wallach.   

Abstract

The etiology of the high prevalence of substance use disorders in patients with severe mental illness (schizophrenia or bipolar disorder) is unclear. We review the evidence of different theories of increased comorbidity, organized according to four general models: common factor models, secondary substance use disorder models, secondary psychiatric disorder models, and bidirectional models. Among common factor models, evidence suggests that antisocial personality disorder accounts for some increased comorbidity. Among secondary substance use disorder models, there is support for the supersensitivity model, which posits that biological vulnerability of psychiatric disorders results in sensitivity to small amounts of alcohol and drugs, leading to substance use disorders. There is minimal support for the self-medication model, but the accumulation of multiple risk factors related to mental illness, including dysphoria, may increase the risk of substance use disorder. Secondary psychiatric disorder models remain to be convincingly demonstrated. Bidirectional models have not been systematically examined. Further clarification of etiologic factors, including the identification of subtypes of dual diagnosis, may have implications for developing more effective prevention efforts and treatment.

Entities:  

Mesh:

Year:  1998        PMID: 9801712

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  94 in total

Review 1.  Cannabis and psychosis.

Authors:  Louisa Degenhardt; Wayne Hall
Journal:  Curr Psychiatry Rep       Date:  2002-06       Impact factor: 5.285

2.  Perceived reasons for substance misuse among persons with a psychiatric disorder.

Authors:  Alexandra B Laudet; Stephen Magura; Howard S Vogel; Edward L Knight
Journal:  Am J Orthopsychiatry       Date:  2004-07

3.  Internet addiction: ongoing research in Asia.

Authors:  Cheng-Fang Yen; Ju-Yu Yen; Chih-Hung Ko
Journal:  World Psychiatry       Date:  2010-06       Impact factor: 49.548

Review 4.  Glial abnormalities in substance use disorders and depression: does shared glutamatergic dysfunction contribute to comorbidity?

Authors:  Mark J Niciu; Ioline D Henter; Gerard Sanacora; Carlos A Zarate
Journal:  World J Biol Psychiatry       Date:  2013-09-12       Impact factor: 4.132

5.  Drug use, drug severity, and help-seeking behaviors of lesbian and bisexual women.

Authors:  Heather L Corliss; Christine E Grella; Vickie M Mays; Susan D Cochran
Journal:  J Womens Health (Larchmt)       Date:  2006-06       Impact factor: 2.681

6.  Substance abuse prevention: practical strategies for psychiatrists in the 21st century.

Authors:  Peter Selby; Franco J Vaccarino
Journal:  World Psychiatry       Date:  2005-02       Impact factor: 49.548

Review 7.  Exercise as an Adjunctive Treatment for Substance Use Disorders: Rationale and Intervention Description.

Authors:  Jeremiah Weinstock; Margaret R Farney; Noel M Elrod; Craig E Henderson; Edward P Weiss
Journal:  J Subst Abuse Treat       Date:  2016-09-09

8.  Secondary prevention of hazardous alcohol consumption in psychiatric out-patients: a randomised controlled study.

Authors:  Sophia Eberhard; Göran Nordström; Peter Höglund; Agneta Ojehagen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-03-18       Impact factor: 4.328

9.  Cannabis use and the risk of developing a psychotic disorder.

Authors:  Wayne Hall; Louisa Degenhardt
Journal:  World Psychiatry       Date:  2008       Impact factor: 49.548

10.  Electronic Health Record-Based Screening for Substance Abuse.

Authors:  Farrokh Alemi; Sanja Avramovic; Mark D Schwartz
Journal:  Big Data       Date:  2018-09-19       Impact factor: 2.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.